Email This Article
Headlines & Perspectives
Sanofi's Prospects Get Leaner
By
Robert Steyer
06/14/07 - 12:28 PM EDT
The stock falls a day after an FDA panel says a weight-loss drug shouldn't be sold in the U.S.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,308.26 | 1,096.07 | 2,180.05 | 34.87 |
Oil *
73.22
|
|
DOWN
132.86
|
DOWN
13.11
|
DOWN
26.86
|
DOWN
1.09
|
10 Yr
3.49%
SPDR Gold
107.34
|
|
-1.27%
|
-1.18%
|
-1.22%
|
-3.03%
|
Data delayed 20 minutes |


Connect with TheStreet